Your browser doesn't support javascript.
loading
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma.
Leleu, Xavier; Martin, Thomas G; Einsele, Hermann; Lyons, Roger M; Durie, Brian G M; Iskander, Karim S; Ailawadhi, Sikander.
Afiliación
  • Leleu X; Department of Hematology, CHU la Miletrie and Inserm CIC 1402, Poitiers, France. Electronic address: xavier.leleu@chu-poitiers.fr.
  • Martin TG; Adult Leukemia and Bone Marrow Transplantation Program, University of California, San Francisco, CA.
  • Einsele H; Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Lyons RM; Department of Hematology, Texas Oncology and US Oncology Research, San Antonio, TX.
  • Durie BGM; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA.
  • Iskander KS; Global Medical Affairs, Amgen Inc, Thousand Oaks, CA.
  • Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, FL.
Clin Lymphoma Myeloma Leuk ; 19(1): 9-22, 2019 01.
Article en En | MEDLINE | ID: mdl-30287200
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasoma / Mieloma Múltiple Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasoma / Mieloma Múltiple Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article